Position in INCY
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$6,276,743
+$1,000,470 QoQ
Shares Held
55,370
-1.2% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.81%
of 13F equity value
Holder Rank
#204
of 849 holders
Holding Since
Jun 2020
23 quarters on record
Common Shares in INCY Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Summit Global Investments holds $20,708,446 across 14 Biotechnology names. INCY ranks #1 (30.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
This page
|
55,370 | $6,276,743 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
7,506 | $4,680,291 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
7,182 | $3,567,514 | |
| 4 | BMRN |
Biomarin Pharmaceutical Inc
|
32,667 | $1,869,205 | |
| 5 | HRMY |
Harmony Biosciences Holdings, Inc.
|
27,034 | $984,307 | |
| 6 | KRYS |
Krystal Biotech, Inc.
|
2,167 | $805,408 | |
| 7 | PTCT |
Ptc Therapeutics, Inc.
|
7,542 | $615,200 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
1,937 | $612,266 |
All Filings in INCY
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,276,743 | 55,370 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $5,276,273 | 56,059 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $6,136,185 | 62,126 | Shares | Sole | 2026-02-18 | |
| 2025-09-30 | $8,889,020 | 104,811 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $7,325,653 | 107,572 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $3,226,770 | 53,291 | Shares | Sole | 2025-04-07 | |
| 2024-06-30 | $5,394,937 | 88,996 | Shares | Sole | 2024-07-22 | |
| 2024-03-31 | $5,936,843 | 104,210 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $4,332,886 | 69,006 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $4,608,832 | 79,779 | Shares | Sole | 2023-10-16 | |
| 2023-06-30 | $14,134,360 | 227,058 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $17,564,283 | 243,037 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $19,269,008 | 239,903 | Shares | Sole | 2023-01-31 | |
| 2022-09-30 | $16,424,760 | 246,470 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $18,067,489 | 237,824 | Shares | Sole | 2022-08-23 | |
| 2022-03-31 | $14,603,034 | 183,871 | Shares | Sole | 2022-04-29 | |
| 2021-12-31 | $2,613,113 | 35,601 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $12,498,701 | 181,720 | Shares | Sole | 2021-11-08 | |
| 2021-06-30 | $6,784,159 | 80,639 | Shares | Sole | 2022-01-28 | |
| 2021-03-31 | $5,075,880 | 62,457 | Shares | Sole | 2022-01-27 | |
| 2020-12-31 | $4,983,780 | 57,298 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $5,548,354 | 61,827 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $6,431,168 | 61,856 | Shares | Sole | 2020-08-11 | |
| No filing history on record for this holder in this stock. | ||||||